8
THE USE OF NANOCOMPOSITE PHOTOSENSITIZERS FOR CANCER THERAPY Georgy S. Terentyuk, Saratov State University , Saratov State Medical University, Russia Daniil S. Chumakov, Saratov State University , Russia Alla B. Bucharskaya, Saratov State Medical University, Russia Galina N. Maslyakova, Saratov State Medical University, Russia Elina A. Genina,Saratov State University, Russia Alexey N. Bashkatov, Saratov State University , Russia Nikolai G . Klebtsov, IBPPM RAS, Russia Boris N. Khlebtsov, IBPPM RAS, Russia

THE USE OF NANOCOMPOSITE PHOTOSENSITIZERS FOR CANCER THERAPY

Embed Size (px)

DESCRIPTION

THE USE OF NANOCOMPOSITE PHOTOSENSITIZERS FOR CANCER THERAPY. Georgy S. Terentyuk, Saratov State University , Saratov State Medical University, Russia Daniil S. Chumakov, Saratov State University , Russia Alla B. Bucharskaya, Saratov State Medical University, Russia - PowerPoint PPT Presentation

Citation preview

Page 1: THE USE OF NANOCOMPOSITE PHOTOSENSITIZERS FOR CANCER THERAPY

THE USE OF NANOCOMPOSITE PHOTOSENSITIZERS FOR CANCER

THERAPY    

Georgy S. Terentyuk, Saratov State University , Saratov State Medical University, RussiaDaniil S. Chumakov, Saratov State University , RussiaAlla B. Bucharskaya, Saratov State Medical University, RussiaGalina N. Maslyakova, Saratov State Medical University, RussiaElina A. Genina,Saratov State University, Russia Alexey N. Bashkatov, Saratov State University , RussiaNikolai G . Klebtsov, IBPPM RAS, RussiaBoris N. Khlebtsov, IBPPM RAS, Russia

Page 2: THE USE OF NANOCOMPOSITE PHOTOSENSITIZERS FOR CANCER THERAPY

to evaluate the antitumor efficiency of nanophotosensitizers - gold nanorods modified with hematoporphyrin on transplanted rat tumors by morphological method

PURPOSE OF THE RESEARCH

TEM imaging of gold nanorods

Page 3: THE USE OF NANOCOMPOSITE PHOTOSENSITIZERS FOR CANCER THERAPY

Materials and methods30 mature outbred male rats with transplanted cholangiocarcinoma line PC-1 (V≥10 cm 3) 

Gold nanorods coated silica and functionalized hematoporphyrin. Synthesized by seed-mediated 

technology  in IBPPM RAS, Saratov                 (L= 102 ±12 nm, d= 75 ± 6  nm, r= 1,4 ± 0,2)Max  extinction – 810 nm, 632 nm, optical density 20 

4 experimental groups and control group of animals  (6 animals per group)

Intratumor injection of  gold nanocomposites (2 ml) 

Simultaneous irradiation of two lasers with wavelengths of 808 nm and 630 nm, both lasers are focused  on one area of the tumor tissue. The power density of near-

infrared laser was 2.3 W/cm2. The power density of the red laser was 0.86 mW/cm2.

Page 4: THE USE OF NANOCOMPOSITE PHOTOSENSITIZERS FOR CANCER THERAPY

Animals with transplanted tumors were divided into groups:1. Control group - without any exposure 2. Comparison group 1. Intratumoral administration of saline.

Irradiation of near infrared laser.3. Comparison group 2. Intratumoral administration of a

suspension of nanocomposites. Irradiation only near-infrared laser.

4. Comparison group 3. Intratumoral administration of a suspension of nanocomposites. Only red laser irradiation.

5. Experienced group Intratumoral administration of a suspension of nanocomposites. Combined exposure of 2 lasers.

A day later irradiation animals were removed from the experiment and morphological study of tumor biopsy was performed

Design of experiment

Page 5: THE USE OF NANOCOMPOSITE PHOTOSENSITIZERS FOR CANCER THERAPY

Results: irradiation of near infrared laser

Control group with transplanted cholangiocarxcinoma (x246,4)

Comparison group 1. Irradiation of near infrared laser (x246,4)

At only infrared laser irradiation the tumor keeps alveolar structure, the vessels of the connective interlayers are full-blooded and contain red blood cells. Nuclei of tumor cells have different sizes, the areas of necrosis is about 5% from total area .

Page 6: THE USE OF NANOCOMPOSITE PHOTOSENSITIZERS FOR CANCER THERAPY

Results: intratumoral administration of nanocomposites.

Comparison group 2. Only near-infrared laser irradiation (x246,4)

Comparison group 3. Only red laser irradiation (x246,4)

After photothermolysis with photosensitizers the vast fields of necrosis (up to 60%) and foci of neutrophil infiltration were observed in the tumor center. After photodynamic treatment marked necrotic changes were noted in the center in place of influence. The congestion in the vessels and the phenomenon of separation of blood in some vessels were observed. On the periphery of the tumor the necrotic changes are less pronounced, nucleus of tumor cells are stored.

Page 7: THE USE OF NANOCOMPOSITE PHOTOSENSITIZERS FOR CANCER THERAPY

Results: intratumoral administration of nanocomposites and combined exposure of 2 lasers

After combined exposure of red and infrared lasers the extensive fields of necrosis (up to 80-95%)were noted in the center of tumor, foci of neutrophil infiltration was observed. On the periphery of the tumor the necrotic changes are less pronounced.

Experienced group after combined irradiation (x 246,6)

Page 8: THE USE OF NANOCOMPOSITE PHOTOSENSITIZERS FOR CANCER THERAPY

Conclusions

The combined therapy of tumor with use of nanocomposite photosensitizers for intensification of photothermolysis and photodinamic effects is more efficient than separate photodynamic and photothermal effects. The gold nanocomposites are attractive agents for combination therapy in cancer treatment.